Skip to main content

Table 2 Clinical data of the patients used for the study

From: MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures

Patient characteristics

Retrospective set (123)

Prospective set (108)

p-value

Date of diagnosis

2008–2014

2015–2018

-

Median follow-up

37.27 months (IQR 14.54–65.69)

25 months (IQR 16.91–31.56)

< 0.001

Gender

M

F

70 (57%)

53 (43%)

65 (60%)

43 (40%)

0.6884

Median age

61 years (IQR 54.25–69)

60 years (IQR 50–72)

0.8574

cTNM 8th edition

III

IVa/b

36 (29%)

87 (71%)

18 (17%)

90 (83%)

0.0291

Smoking status

Current/Former

Never

Unknown

83 (67%)

40 (33%)

0

46 (43%)

37 (34%)

25 (23%)

< 0.001

Treatment

Including surgery

Not including surgery

107 (87%)

16 (13%)

98 (91%)

10 (9%)

0.41

  1. Quantitative variables are displayed as median and interquartile range (IQR). Statistical tests (Mann-Whitney, chi-squared) are used to evaluate potential statistical differences between the patient cohorts.